Showing results (661-670 of 3,636) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|May 29, 2026
Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER studyLetizia Pontolillo, Elisabetta Munzone, Paolo Vigneri, et al.Breast (Edinburgh, Scotland)|June 1, 2026
Idiopathic granulomatous mastitis: A scoping review to determine the quality and geography of the evidence baseDaniel Ahari, Leah Argus, Rute Castelhano, et al.Breast (Edinburgh, Scotland)|February 26, 2011
Factors affecting estrogen receptor status in a multiracial Asian country: an analysis of 3557 casesC H Yip, N Bhoo Pathy, C S Uiterwaal, et al.Breast (Edinburgh, Scotland)|June 4, 2026
Enhanced prognostic score for breast cancer brain metastases incorporating contemporary clinical features and leptomeningeal disease: Development and validationYun Hwa Roh, Dongyeong Kim, Ho Sung Kim, et al.Breast (Edinburgh, Scotland)|April 18, 2026
Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert ConsensusCarmine De Angelis, Dario de Biase, Lorenzo Gerratana, et al.Breast (Edinburgh, Scotland)|May 13, 2026
Evaluation of a novel communication workshop for healthcare professionals working with metastatic breast cancer patientsLesley J Fallowfield, Ivonne Solis-Trapala, Ruth Habibi, et al.Breast (Edinburgh, Scotland)|June 13, 2026
A nationwide population-based study on the incidence and prognosis of HER2-positive breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapyAntonis Valachis, Xingrong Liu, Balazs Acs, et al.Breast (Edinburgh, Scotland)|December 25, 2016
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspectivePaolo Marchetti, Nicolai Maass, Joseph Gligorov, et al.Breast (Edinburgh, Scotland)|December 30, 2016
Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypesJ Barrou, M Bannier, M Cohen, et al.Breast (Edinburgh, Scotland)|November 5, 2016
A medieval description of metastatic breast cancer; from Avicenna's view pointMohammad M Zarshenas, Afshin Mohammadi-BardboriPageof 364